NCT03547440

Brief Summary

Diabetes Mellitus Type I is the chronic metabolic disease of childhood with the highest incidence in developed countries. Over the past 10 years the incidence of diabetes has been increased especially in immigrants children. The objective of the investigator's project is to evaluate factors that influence the T1DM course in immigrant and Italian children through an analysis of the relationship between socio-cultural determinants, lifestyles and metabolic control. The study population will consist of 100 children with first diagnosis of T1DM divided into two cohorts (Italian and immigrant children). The project consists in a follow-up of 18 months from first visit and will include laboratory tests, two questionnaires and determination of a microbiological indicator of the microbiota and levels of 25-hydroxyvitamin D. The research hypothesis is that the two groups of study population show a different metabolic control of diabetes due to differences in access to care, compliance to therapy and type of nutrition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2015

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2015

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
11 months until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2018

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

2.3 years

First QC Date

March 16, 2017

Last Update Submit

December 3, 2024

Conditions

Keywords

Type 1 Diabetes MellitusimmigrantmicrobiotabioindicatorMethanobrevibacter smithii

Outcome Measures

Primary Outcomes (1)

  • Metabolic control

    The blood pH of the patients are measured at the onset to define ketoacidosis following normal standard hospital procedure.

    at onset

Secondary Outcomes (7)

  • Body mass index

    at onset

  • Glycated hemoglobin

    at onset

  • Diet behaviour

    at onset

  • vitamin D

    at the onset

  • Microbiome bioindicators

    at onset

  • +2 more secondary outcomes

Other Outcomes (1)

  • Metabolic control 2

    at onset

Study Arms (2)

type 1 diabetes mellitus

Children with type 1 diabetes mellitus, usually not obese, with diabetic ketoacidosis. They could be with or without stationary metabolic profile. They are recruited at the onset of the T1DM into the Torino and Novara Pediatric Hospitals and then they are divided in relation to the ethnicity.

Control healthy

Healthy children without relevant metabolic or systemic co-morbility. They are recruited from orthopedy department of the Torino and Novara Pediatric hospitals and then they are divided in relation to the ethnicity

Eligibility Criteria

AgeUp to 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children living in the Piedmont region. Primary care clinic of Torino and Novara (diabetologia for cases and orthopedia and general population for controls)

You may qualify if:

  • Cases migrants : T1DM's recent diagnosis
  • Italian cases : comparable to individual characteristics, living area, mainly age and gender
  • Controls: healthy children (two control comparable for each case)

You may not qualify if:

  • Children with parents of mixed origin
  • Children with chronic gastrointestinal disorders (such as irritable bowel syndrome) or other relevant metabolic or systemic co-morbility
  • Children who used antibiotics or with diarrhea in the last 15 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Pediatric Clinic - Hospital "Maggiore della Carità" of Novara

Novara, Italy

Location

Dept. of Public Health and Pediatrics

Torino, 10126, Italy

Location

Dep. of Medicine Science

Turin, Italy

Location

Biospecimen

Retention: SAMPLES WITH DNA

stool samples (from all the participants) and blood samples (only from T1DM) patients

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Roberta T Siliquini, Prof.

    University of Turin - Hygiene and Preventive Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
18 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 16, 2017

First Posted

June 6, 2018

Study Start

March 18, 2015

Primary Completion

June 30, 2017

Study Completion

September 18, 2018

Last Updated

December 4, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations